BRAVA: Building Resilience and Attachment in Vulnerable Adolescents

Not Applicable

Completed

• Conditions: Suicidal Ideation; Suicide and Self-harm

• Registration Number: NCT04751968
• Lead Sponsor: Children's Hospital of Eastern Ontario

Brief Summary

The prevalence of suicidal ideation (SI) among adolescents in North America is high, making it critical to develop evidence-based brief interventions for adolescents with SI that target healthy coping skills and relationships. BRAVA is a novel brief group intervention for adolescents with mild to moderate SI and their caregivers; youth are taught skills for coping and relating more effectively with others. Caregivers learn about adolescent development, effective parenting and the importance of connection. The goal of the randomized controlled trial is to assess the efficacy of a virtually-delivered, brief group intervention for adolescents with mild to moderate SI and their caregivers in reducing SI.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-02-02
• Study First Submitted QC: 2021-02-10
• Study First Posted: 2021-02-12
• Study Start: 2021-04-12
• Primary Completion: 2023-05-25
• Study Completion: 2023-08-25
• Status Verified: 2024-05
• Last Update Submitted: 2024-05-03
• Last Update Posted: 2024-05-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 99

Inclusion Criteria

• Adolescents 13 years old to 17.5 years old
• Mild to moderate suicidal ideation (SI without plan or gesture; 1 on the HEADS-ED) (Cappelli, et al., 2012)
• Interested in study participation
• Access to an electronic device with internet and email capabilities, and a functioning camera and microphone

Exclusion Criteria

• SI with plan or gesture (2 on HEADS ED; indicated plan or gesture)
• Comorbid disorders (psychosis, schizophrenia, developmental disabilities, major substance abuse, and severe eating disorders).
• Referring clinician has identified an externalizing disorder as a primary diagnosis or primary concern (e.g. Conduct Disorder)
• Currently participating in regular psychotherapy at least one time per week
• Currently under Children's Aid Society care
• Currently in the CHEO ED on a Form 1 or Form 2, or placed on a Section 17.
• Express difficulty with reading and writing

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Suicidal Ideation	6 weeks	Suicidal ideation will be measured using the Suicidal Ideation Questionnaire Junior (Reynolds, 1988). A decreased score in suicidal ideation over 6-weeks will indicate a positive outcome.

Secondary Outcome Measures

Name	Time	Method
Depression and Anxiety	6 weeks	We will be assessing youth depression and anxiety with the youth version of the Revised Child Anxiety and Depression Scale (Chorpita et al., 2000). A decreased score in depression and anxiety over 6-weeks will indicate a positive outcome.
Attachment	6 weeks	We will be assessing caregiver attachment with the adolescent version of the Adolescent Attachment Anxiety \& Avoidance Inventory (Morretti \& Obsuth, 2009). A decreased score in attachment between the adolescent and caregiver over 6-weeks will indicate a positive outcome.
Family Functioning	6 weeks	Family functioning using the Family Assessment Device (Epstein, Baldwin, \& Bishop, 1983). A decreased score in family functioning over 6-weeks will indicate a positive outcome.

Trial Locations

Locations (1)

CHEO; 🇨🇦 Ottawa, Ontario, Canada